What does this research mean for the field?

CST4 promotes epithelial-mesenchymal transition (EMT) and tumor progression in ovarian cancer via the Wnt/β-catenin signaling pathway. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to investigate CST4's role in enhancing epithelial-mesenchymal transition (EMT) and tumor advancement in ovarian cancer.

March 2, 2026Discover Oncology0 citationsOpen Access

CST4 promotes EMT and tumor progression in ovarian cancer via Wnt/β-catenin signaling

JSJunjun Shao WGWei Gao YLYuzhi Li

Key Points

The research aims to investigate CST4's role in enhancing epithelial-mesenchymal transition (EMT) and tumor advancement in ovarian cancer.
Investigated CST4 expression in ovarian cancer cells
Analyzed the effects of CST4 on EMT markers
Assessed the involvement of Wnt/β-catenin signaling pathway
CST4 expression correlates with increased EMT markers
CST4 promotes tumor cell invasion and growth
Wnt/β-catenin signaling pathway mediates the effects of CST4

Abstract

CST4 is a novel oncogenic regulator in OC that promotes EMT and tumor aggressiveness via the Wnt/β-catenin signaling pathway. It may serve as an independent prognostic biomarker and potential therapeutic target for OC.

Demander à l'IA

Bookmark

View Full Paper